Arcadia Biosciences, Inc.: 10-Q filed 2015-11-05
What Arcadia Biosciences, Inc. reported in its quarterly report filed 2015-11-05 (fiscal Q3 2015): 28 published measures, 78 facts as tagged in accession 0001564590-15-009725.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-05
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001564590-15-009725 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Arcadia Biosciences, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 79,973,000 | USD | |
| At 2014-12-31 | 24,889,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 36,140,000 | USD | |
| At 2014-12-31 | 26,774,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 43,833,000 | USD | |
| At 2014-12-31 | -84,766,000 | USD | |
| At 2013-12-31 | -17,297,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 62,966,000 | USD | |
| At 2014-12-31 | 16,571,000 | USD | |
| At 2014-09-30 | 21,170,000 | USD | |
| At 2013-12-31 | 2,835,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -4,619,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -14,099,000 | USD | 273 |
| 2014-01-01 to 2014-12-31 | -18,339,000 | USD | 365 |
| 2014-07-01 to 2014-09-30 | -7,064,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -16,351,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 80,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 40,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -128,069,000 | USD | |
| At 2014-12-31 | -113,970,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -97,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 222,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 43,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 235,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 597,000 | USD | |
| At 2014-12-31 | 728,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 1,205,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 595,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -4,235,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -11,493,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -5,943,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -13,523,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 76,642,000 | USD | |
| At 2014-12-31 | 18,695,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 766,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,008,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 265,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,048,000 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 10,895,000 | USD | |
| At 2014-12-31 | 11,269,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 685,000 | USD | |
| At 2014-12-31 | 1,042,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 6,058,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 15,561,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 7,445,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 17,707,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 598,000 | USD | |
| At 2014-12-31 | 424,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 2,818,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 8,241,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 1,966,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 7,833,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 3,179,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 7,097,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 3,684,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 7,942,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 43,931,094 | shares | |
| At 2014-12-31 | 2,074,030 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 19,462,000 | USD | |
| At 2014-12-31 | 9,924,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 102,000 | USD | |
| At 2014-12-31 | 2,817,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 3,000,000 | USD | |
| At 2014-12-31 | 3,000,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 672,000 | USD | |
| At 2014-12-31 | 278,000 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -4,619,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -16,870,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -8,634,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -18,439,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 285,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -376,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -813,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -613,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -357,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -591,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 157,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -550,000 | USD | 273 |
Inspect the source
- Entity
- Arcadia Biosciences, Inc. / CIK 0001469443
- Captured
- 2026-09-20T09:07:21.204Z
- SEC response SHA-256
f806f5e943ca77a8b894ab622b0441684ca24fc4c2b017f1608fffb332b90f9d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001469443.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))